Find here a listing of the latest industry news in genomics, genetics, precision medicine, and beyond. We will update and add to this page on a regular basis. This page is not a compilation of all relevant information but rather contains some key highlights that we consider to be of importance to share with the community.
Sign-Up for our newsletter and never miss out on the latest news and updates.
Check out our News Portal with real-time listing of news and articles in genomics, genetics, precision medicine, and beyond.
News for the month March 2026
Funding / IPO
AL / ML / DL / GenAI / LLM / ChatGPT/Agentic AI
- **Microsoft unveils Copilot Health as an AI health companion for consumers Copilot Health is an AI assistant for consumers that can review medical records, help them prepare for doctor appointments and offer personalized insights based on their health data
- **AWS launches a new AI agent platform specifically for healthcare
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
Miscellaneous
- **Confidential health records from UK BioBank project exposed online The UK Biobank holds the medical records of 500,000 British volunteers, and is one of the world’s most comprehensive stores of health information and is credited with driving breakthroughs in cancer, dementia and diabetes research. It turns out confidential health data has been exposed online on dozens of occasions, a Guardian investigation can reveal, raising questions about the safeguarding of patient records by one of the UK’s flagship medical research projects.
- **White House lifts hold on NIH research spending
Publications
News for the month February 2026
Funding / IPO
- **Syndex Bio Unveils mcPCR Technology at AGBT 2026 Following $15.5M Seed Financing (AGBT 2026)
- Barshop Institute to receive up to $38 million from ARPA-H, anchoring UT San Antonio as a national leader in aging and healthy longevity science
- Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
- Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansion
- Women’s health clinic Midi Health closes $100M series D as it aims to scale a national healthcare company
- Cancer Detection Startup Secures $4M to Expand Access in Underserved Communities
- **Carbon Health files for bankruptcy, seeking to sell or restructure
- Coral Care closes $13M Series A for developmental pediatric therapy
Mergers & Acquisitions
- Nexus Precision Health Acquires Leal Health to Accelerate Precision Medicine at Scale
- Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences
- **Complete Genomics Enters Definitive Agreement to Be Acquired by Swiss Rockets AG
- ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
(Omics) Data Platform / Sequencing / Analysis / Instruments (AGBT 2026)
- Illumina
- **Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
- **Illumina launches TruPath Genome, setting a new standard in genomic insight
- Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
- **Complete Genomics announced it is commencing shipments of DNBSEQ-T7+
- **Element Biosciences Introduces VITARI™, Redefining What High-Throughput Sequencing Makes Possible
- **Ultima Genomics Introduces the Next Generation of Sequencing at Scale with the Launch of the UG200™ Series and Next Generation Solaris 2.0 Workflows Delivering Higher Output, Better Performance and More Flexible Wafer Configurations
- Bruker to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
- Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow
- biomodal and Element Biosciences Combine Duet Multiomic and High-Throughput Sequencing Capabilities
- Volta Labs Announces Major Product Launches and Industry-Shaping Partnerships with Roche and Watchmaker Genomics
- seqWell Announces Launch of MosaiX™ DNA Library Prep Kit for High Performance NGS Applications
- CoolMPS™ 600: Accurate and Affordable Long MPS/NGS Reads on a Mid-Throughput Platform
- Integrated DNA Technologies Unveils NGS Innovation Roadmap to Accelerate the Future of Cancer Research
- **Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample
- New England Biolabs® launches Monarch® Mag Cell-free DNA (cfDNA) Extraction Kit to enable scalable, reproducible cfDNA isolation from biofluids
- Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Diagnostics / Genomic / Genetic Testing / CDx
Precision Medicine
- Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill
- Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
AL / ML / DL / GenAI / LLM / ChatGPT/Agentic AI
- Lotus Health nabs $35M for AI doctor that sees patients for free
- Epic launches AI Charting, potentially scrambling the ambient scribe market
- FDA taps AI executive to lead digital health center
Miscellaneous
- AGBT Names 2026 Next Gen Leadership Award Recipients for General Meeting (AGBT 2026)
- White House launches direct-to-consumer drug site TrumpRx
- **TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics
- What’s Next for Proteomics, According to Industry Experts
- Eppendorf collaborates with Dubai Police to automate forensics laboratories
- Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally
Publications
- Multi-System Genetic Architecture of Hypermobile Ehlers–Danlos Syndrome: Integrating Machine Learning with Subject-Level Genomic Analysis
- From correlation to causation: cell-type-specific gene regulatory networks in Alzheimer’s disease Causal gene mapping identifies key drivers of Alzheimer’s disease progression
- Causal parametric language mapping with electrical stimulation during awake neurosurgery Study refines the limits of brain mapping
News for the month January 2026
Funding / IPO
- **OpenEvidence clinches $250M series D as AI platform sees explosive growth with doctors
- 2025 year-end digital health funding overview: A tale of two markets A Rock Health report
- Xella Health Raises $3.7 Million Pre-Seed to Launch Women’s Precision Health Platform
- Carna Health Secures $8 Million to Expand Access to Scalable Chronic Kidney Disease Screening Solutions Globally Funding to accelerate innovation and growth following strategic partnership with Siemens Healthineers
- RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide
- Flywheel Raises $27.5 Million And Expands Clinical Trial And Medical Device Offerings
- Protege Raises $30M Led by a16z to Unlock Access to Data for AI Development The company provides licensed, curated access to real-world and proprietary datasets across domains such as media, audio, and healthcare, supporting AI training and evaluation for major global AI companies.
- bit.bio secures $50 million Series C to scale human cell programming technology
Mergers & Acquisitions
- JPM26
- Novartis pays $50M for China biotech’s cancer therapy asset
- Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B
- Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
- Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale
- Eli Lilly strikes $2.5B Scorpion buyout in twist to breast cancer tale
- **OpenAI acquires health-care technology startup Torch for $60 million
- Hippocratic AI acquires Grove AI, taps life sciences leaders to focus on biopharma, medtech
- **bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies This strategic transaction, bioMérieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide
Precision Medicine
(Omics) Data Platform / Sequencing / Analysis / Instruments
Diagnostics / Genomic / Genetic Testing / CDx
- **10x Genomics to Advance REsearch in Diagnostics Applications of Tumor Single Cell Profiling 10x announced clinical collaborations with two Boston-based institutions, Brigham & Women’s Hospital and Dana-Farber Cancer Institute, as well as the New York-based Cancer Research Institute. The company also committed to building its own CLIA-certified laboratory within about a year, with the goal of enabling clinical deployment of diagnostics that will come up with these kinds of collaborations.
AL / ML / DL / GenAI / LLM / ChatGPT/Agentic AI
- JPM26
- **Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment
- **Anthropic joins OpenAI’s push into health care with new Claude tools Anthropic’s new offerings allow users and providers to work with medical data, mimicking similar moves by OpenAI.
- **OpenAI launches ChatGPT Health in a push to become a hub for personal health data
- FDA clears Aidoc tool to detect 14 different conditions from a CT scan It’s one of the first instances of the agency clearing an AI tool that looks for multiple conditions
- Amazon launches AI health-care tool for One Medical members
- Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere
- Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
- Exclusive: 40 million people turn to ChatGPT for health care
Miscellaneous
- Walmart dips its toe back into healthcare with new digital platform
- Trump releases health care plan amid pressure over affordability President’s plan is light on details, but could shape debate in Congress
- Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight loss pill
- FDA announces sweeping changes to oversight of wearables, AI-enabled devices The changes could allow unregulated generative artificial intelligence tools into clinical workflows
- **Illumina Appoints Dr. Eric Green as Chief Medical Officer
Publications
- De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa
- **A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma Researches developed an Immune Atlas of MM by generating profiles of 1,397,272 single cells from the bone marrow (BM) of 337 newly diagnosed participants and characterized immune and hematopoietic cell populations
